@abahealthlaw From an FMV compliance standpoint, I think attorneys really need to stay on top of their clients to unwind or reassess actions taken under temporary blanket waivers to avoid downstream compensation issues. #COVIDlawchat
@Matt_R_Fisher@Health_Atty_MI@abahealthlaw A lot of that is really going to come down to stimulus funds, support payments, and financial health going into this crisis. I have always harped on maintaining adequate working capital levels in my valuations. #COVIDlawchat
@JoelGWakefield@abahealthlaw The income method will be the only tool in our belt for some time, but the assumptions will need to be closely scrutinized and the pricing of risk (rate of return) will necessarily be much higher #COVIDlawchat
@Matt_R_Fisher@abahealthlaw I don't disagree, but FMV is always a reflection of what is known or knowable at the time of the transaction. Right now, there exists no precedent for assessing the future, nor do we know what additional regulatory actions will be taken #COVIDLawChat
@abahealthlaw I also expect the use of extraordinary assumptions in appraisals “An assumption, directly related to a specific assignment, as of the effective date of the appraisal results, which, if found to be false, could alter the appraiser’s opinions or conclusions.” #covidlawchat
#COVIDLawChat the team @RootValuation are all working remotely, but we are adjusting well. Business valuation/transaction work has definitely slowed during this lockdown, but we are still working on a number of compensation arrangements unrelated to COVID-19
#COVIDLawChat I am the founder of @RootValuation a healthcare-focused valuation firm. Looking forward to the discussion and offering my thoughts on #FMV
#COVIDLawChat we recently added a blog post to our website with some thoughts and considerations for business transactions/valuations in the wake of COVID-19. Looking forward to sharing additional thoughts as the chat goes live. https://t.co/NBH3Ve2QCK